NEW YORK, Jan. 17 (GenomeWeb News) - Clinical Data has bought back a total of 130,000 warrants from Xmark Opportunity Fund for total cash consideration of $130,000, the company said today. Each repurchased warrant carried the right to buy Clinical Data common stock at a price of $28.50 per share.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.